Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDNL.L Share News (DNL)

  • There is currently no data for DNL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK EXECUTIVE CHANGE SUMMARY: Abcam Board Confirms Support For Chair

Mon, 11th May 2020 13:07

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday and Thursday last week and not separately reported by Alliance News:

----------

Abcam PLC - antibodies for scientific research - Notes the announcement back in March that Peter Allen has resigned as chair of Diurnal Group PLC from June 30. At the Abcam annual general meeting back in November, 41% of shareholders voted against the resolution to re-elect Allen as chair of Abcam, citing concerns about his multiple commitments. "The board is confident that Mr Allen discharges effectively his role as chairman notwithstanding his other board commitments. The board believe that Mr Allen plays an important role in helping drive the strategy of the group and remain fully supportive of the role and guidance he provides to the company," Abcam said Monday.

----------

Aura Energy Ltd - gold and vanadium project development - Adds Paul Heber and Robert Craigie to board immediately as non-executives. Australia-based Aura noted Heber is UK-based, and it has wanted to appoint a UK director since its AIM listing. Heber is an investment manager and stockbroker who has worked at SG Hambro, National Westminster Bank and WI Carr. Craigie is CFO of Circa Group Ltd in Melbourne.

----------

CentralNic Group PLC - internet domain names and web services - Non-Executive Director Mike Turner resigns immediately to take up new full-time role as a partner with an unnamed international law firm.

----------

ThinkSmart Ltd - digital payments - Non-Executive Director Roger McDowell to retire at annual general meeting, expected to be held in November. McDowell has served since December 2016, when the company listed on AIM.

----------

Gooch & Housego PLC - optical components maker - Hires Louise Evans as non-executive director, effective immediately. Evans was finance director of Braemar Shipping Services PLC, and prior to that of Williams Grand Prix Holdings PLC. She is currently a non-executive director of AB Dynamics PLC.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
11 Oct 2021 19:51

TRADING UPDATES: Baron Oil boosts P2478 stake amid Upland farmout pact

TRADING UPDATES: Baron Oil boosts P2478 stake amid Upland farmout pact

Read more
14 Sep 2021 17:46

TRADING UPDATES: Strong annual results from Springfield, Fiske

TRADING UPDATES: Strong annual results from Springfield, Fiske

Read more
13 Sep 2021 20:23

IN BRIEF: Diurnal's Efmody adrenal treatment launches in UK

IN BRIEF: Diurnal's Efmody adrenal treatment launches in UK

Read more
7 Sep 2021 16:25

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
1 Sep 2021 19:34

TRADING UPDATES: Power Metal hits "bullseye"; Instem makes acquisition

TRADING UPDATES: Power Metal hits "bullseye"; Instem makes acquisition

Read more
28 Jul 2021 18:07

TRADING UPDATES: United Oil & Gas in North Sea sale; Trifast confident

TRADING UPDATES: United Oil & Gas in North Sea sale; Trifast confident

Read more
12 Jul 2021 10:10

Diurnal agrees special protocol with FDA for Chronocort study

(Sharecast News) - Specialty pharmaceutical company Diurnal announced on Monday that the US Food and Drug Administration (FDA) has agreed a special protocol assessment (SPA) for 'Chronocort', or modified-release hydrocortisone, for the design, endpoints and statistical analysis approach of a pivotal study of the product, for the treatment for congenital adrenal hyperplasia (CAH).

Read more
2 Jul 2021 10:02

Diurnal gets UK approval for 'Efmody' treatment

(Sharecast News) - Speciality pharmaceutical company Diurnal Group announced on Friday that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted a marketing authorisation for 'Efmody', or hydrocortisone modified-release hard capsules, as treatment for adult and adolescent patients with the rare congenital adrenal hyperplasia (CAH) condition.

Read more
2 Jul 2021 10:01

Diurnal gets UK approval for Efmody drug following EU authorisation

Diurnal gets UK approval for Efmody drug following EU authorisation

Read more
29 Jun 2021 17:10

TRADING UPDATES: Gaming Realms BetMGM deal; Argo bitcoin-backed loan

TRADING UPDATES: Gaming Realms BetMGM deal; Argo bitcoin-backed loan

Read more
1 Jun 2021 20:24

TRADING UPDATES: CML plans AIM move; IronRidge to demerge gold assets

TRADING UPDATES: CML plans AIM move; IronRidge to demerge gold assets

Read more
28 May 2021 19:41

TRADING UPDATES: Odyssean IT swings to profit; BMO Cap ups dividend

TRADING UPDATES: Odyssean IT swings to profit; BMO Cap ups dividend

Read more
12 May 2021 15:30

IN BRIEF: Diurnal extends Citrine licensing deal for Efmody in China

IN BRIEF: Diurnal extends Citrine licensing deal for Efmody in China

Read more
23 Apr 2021 12:56

IN BRIEF: Diurnal gets another patent for adrenal insufficiency asset

IN BRIEF: Diurnal gets another patent for adrenal insufficiency asset

Read more
23 Apr 2021 10:31

Diurnal granted European patent for Alkindi

(Sharecast News) - Hormonal disease-focussed speciality pharmaceutical company Diurnal Group announced the grant of a patent for 'Alkindi', or hydrocortisone granules in capsules for opening, by the European Patent Office on Friday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.